Research at Berlin-Buch

Research

The Berlin-Buch Campus is a unique site for medical research and development in Germany. The Max Delbrück Center for Molecular Medicine (MDC), founded in 1992 as a model for clinical research from three institutes of the GDR Academy of Sciences, was the initial driving force for the development of the campus into a research and biotechnology site of supraregional significance. Since 2000, the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has played a major role in this development.

Today, on the 32-hectare site which can look back on a long scientific tradition, institutes for basic medical research, research clinics and biotechnology companies are located in close proximity to each other. Buch's researchers, doctors and entrepreneurs are collaborating in the development of new treatments and diagnostic procedures for cancer, cardiovascular and nervous system diseases.

A modern Congress Center with integrated laboratories on the campus offers multiple opportunities for scientific interaction.

News research

Talk in the Cube: IP STRATEGIES IN BIOTECHNOLOGY

We are excited to continue the Talks in the Cube with an expert discussion focused on Strategies for Intellectual Property Rights in Biotechnology.

more ...

Professorship awarded to Ashley Sanders

Dr. Ashley Sanders, Group Leader of the Genome Instability and Somatic Mosaicism lab at the Berlin Institute for Medical Systems Biology of the Max Delbrück Center (MDC-BIMSB), has been awarded a W3 p...

more ...

Klaus Rajewsky honored for a lifetime of achievements

The European Federation of Immunological Societies is awarding Klaus Rajewsky of the Max Delbrück Center its first-ever Lifetime Achievement Award. The 88-year-old Rajewsky, who remains active in rese...

more ...

Events Campus

Keine aktuellen Termine!

Sponsoren der Website: